Osiris Therapeutics, Inc. (OSIR) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
7015 ALBERT EINSTEIN DRIVE COLUMBIA, MD 21046 |
| State of Incorp. | MD |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2836 - Biological Products, Except Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2018 | 12/31/2017 | 12/31/2014 | 12/31/2013 | 12/31/2012 | |||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash, cash equivalents, and short-term investments | 27,888 | 50,104 | 59,010 | 34,092 | |||
| Cash and cash equivalents | 3,081 | 2,208 | 2,416 | 1,854 | |||
| Short-term investments | 24,807 | 47,896 | 56,594 | 32,238 | |||
| Receivables | 30,841 | 34,258 | 7,459 | 3,063 | |||
| Inventory, net of allowances, customer advances and progress billings | 11,278 | 10,924 | 1,929 | 1,278 | |||
| Inventory | 11,278 | 10,924 | 1,929 | 1,278 | |||
| Disposal group, including discontinued operation | 91 | ||||||
| Prepaid expense and other current assets | ✕ | ✕ | ✕ | ✕ | 603 | ||
| Other undisclosed current assets | 2,920 | 650 | 15,620 | ||||
| Total current assets: | 72,927 | 95,936 | 84,109 | 39,036 | |||
| Noncurrent Assets | |||||||
| Property, plant and equipment | 3,587 | 2,087 | 1,896 | 2,111 | |||
| Restricted cash and investments | 243 | 317 | |||||
| Other noncurrent assets | ✕ | ||||||
| Deferred tax assets, net | |||||||
| Other undisclosed noncurrent assets | 1,608 | 95 | 5,849 | ||||
| Total noncurrent assets: | 5,195 | 2,182 | 7,988 | 2,428 | |||
| TOTAL ASSETS: | 78,122 | 98,118 | 92,097 | 41,464 | |||
| LIABILITIES AND EQUITY | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued liabilities, including: | 14,668 | 8,854 | 4,842 | 4,999 | |||
| Accounts payable | 5,269 | ||||||
| Accrued liabilities | 9,399 | ||||||
| Other undisclosed accounts payable and accrued liabilities | 8,854 | 4,842 | 4,999 | ||||
| Debt | 45 | 45 | 44 | ||||
| Deferred compensation liability | 1,667 | ||||||
| Disposal group, including discontinued operation | 57 | ||||||
| Other liabilities | 1,934 | ||||||
| Deferred tax liabilities | 5,849 | ||||||
| Other undisclosed current liabilities | 18,500 | ||||||
| Total current liabilities: | 35,102 | 10,566 | 10,793 | 5,043 | |||
| Noncurrent Liabilities | |||||||
| Long-term debt and lease obligation | 72 | 117 | 162 | ||||
| Capital lease obligations | 72 | 117 | 162 | ||||
| Liabilities, other than long-term debt | 1,626 | 3,589 | 355 | 369 | |||
| Other liabilities | 1,626 | 3,589 | 355 | 369 | |||
| Other undisclosed noncurrent liabilities | (72) | (117) | |||||
| Total noncurrent liabilities: | 1,626 | 3,589 | 355 | 531 | |||
| Total liabilities: | 36,728 | 14,155 | 11,148 | 5,574 | |||
| Equity | |||||||
| Equity, attributable to parent | 41,394 | 83,963 | 80,949 | 35,890 | |||
| Common stock | 35 | 35 | 34 | 33 | |||
| Additional paid in capital | 283,905 | 287,525 | 282,702 | 279,269 | |||
| Accumulated other comprehensive loss | (208) | (54) | (33) | (20) | |||
| Accumulated deficit | (242,338) | (203,543) | (201,754) | (243,392) | |||
| Total equity: | 41,394 | 83,963 | 80,949 | 35,890 | |||
| TOTAL LIABILITIES AND EQUITY: | 78,122 | 98,118 | 92,097 | 41,464 | |||
Income Statement (P&L) ($ in thousands)
| 12/31/2018 | 12/31/2017 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|---|---|
| Revenues | 118,514 | 59,867 | 24,947 | 11,804 | ||
| Revenue, net | ✕ | 118,514 | 59,867 | 24,947 | 11,804 | |
| Cost of revenue (Cost of Goods and Services Sold) | (32,681) | (13,452) | (6,718) | (2,576) | ||
| Gross profit: | 85,833 | 46,415 | 18,229 | 9,228 | ||
| Operating expenses | (87,822) | (44,978) | (20,485) | (20,404) | ||
| Other undisclosed operating income (loss) | 281 | (577) | 25 | |||
| Operating income (loss): | (1,989) | 1,718 | (2,833) | (11,151) | ||
| Nonoperating income (expense) (Other Nonoperating Income (Expense)) | (645) | (1,771) | 414 | 49 | ||
| Income (loss) from continuing operations before income taxes: | (2,634) | (53) | (2,419) | (11,102) | ||
| Income tax expense (benefit) | 1,398 | (193) | 1,326 | 37 | ||
| Income (loss) from continuing operations: | (1,236) | (246) | (1,093) | (11,065) | ||
| Income (loss) before gain (loss) on sale of properties: | (1,236) | (1,187) | (1,093) | (11,065) | ||
| Income (loss) from discontinued operations | (941) | |||||
| Other undisclosed net income | 10,021 | |||||
| Net income (loss) attributable to parent: | 8,785 | (1,187) | (1,093) | (11,065) | ||
| Other undisclosed net income (loss) available to common stockholders, basic | (602) | 42,731 | ||||
| Net income (loss) available to common stockholders, diluted: | 8,785 | (1,789) | 41,638 | (11,065) | ||
Comprehensive Income ($ in thousands)
| 12/31/2018 | 12/31/2017 | 12/31/2014 | 12/31/2013 | 12/31/2012 | ||
|---|---|---|---|---|---|---|
| Net income (loss): | 8,785 | (1,187) | (1,093) | (11,065) | ||
| Comprehensive income (loss): | 8,785 | (1,187) | (1,093) | (11,065) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (119) | (623) | 42,718 | (40) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | 8,666 | (1,810) | 41,625 | (11,105) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.